Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
24,5 GBX | -3,92% | -18,33% | +58,06% |
18/04 | Renalytix chief business officer wordt president | AN |
18/04 | Renalytix plc kondigt wijzigingen in de leiding aan, met ingang van 30 april 2024 | CI |
Vakgebied
Aantal werknemers: 102
Verkoop per activiteit
GBP in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Artificial Intelligence-enabled in Vitro Diagnostics
100,0
%
| 2 | 100,0 % | 3 | 100,0 % | +26,61% |
Verkoop per regio
GBP in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United Kingdom
100,0
%
| 2 | 100,0 % | 3 | 100,0 % | +26,61% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
James McCullough
FOU | Founder | 56 | 15-03-18 |
James Sterling
DFI | Director of Finance/CFO | 54 | 15-03-18 |
Thomas McLain
PSD | President | 66 | 29-07-19 |
Fergus Fleming
CTO | Chief Tech/Sci/R&D Officer | 57 | 15-03-18 |
Michael Donovan
CTO | Chief Tech/Sci/R&D Officer | 70 | 15-03-18 |
Joseph Hutson
PRN | Corporate Officer/Principal | - | 22-07-21 |
Sales & Marketing | - | 07-06-21 | |
Salim Hamir
SEC | Corporate Secretary | - | - |
Jed Fulk
SAM | Sales & Marketing | 64 | 07-10-21 |
Howard Doran
PRN | Corporate Officer/Principal | 63 | 01-09-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Levangie
BRD | Director/Board Member | 73 | 30-08-21 |
Chairman | 72 | 15-03-18 | |
James McCullough
FOU | Founder | 56 | 15-03-18 |
Fergus Fleming
CTO | Chief Tech/Sci/R&D Officer | 57 | 15-03-18 |
Erik Lium
BRD | Director/Board Member | 56 | 01-11-18 |
Catherine Coste
BRD | Director/Board Member | 58 | 30-06-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 154 368 191 | 82 586 459 ( 53,50 %) | 0 | 53,50 % |
Bedrijfsgegevens
Sector
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+58,06% | 40,64 mln. | |
-12,91% | 18,55 mld. | |
-46,21% | 2,65 mld. | |
+18,15% | 1,81 mld. | |
-3,12% | 1,61 mld. | |
+23,78% | 1,21 mld. | |
-10,69% | 1,03 mld. | |
-20,89% | 896 mln. | |
-18,10% | 686 mln. | |
-7,14% | 680 mln. |
- Beurs
- Aandelen
- Koers RENX
- Onderneming Renalytix Plc